State weighs cost of medications and risk of avian flu
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
Minnesota has stockpiled about 85 percent of the antiviral medication it is entitled to buy from drug companies to prepare for a possible avian flu epidemic.
But state health officials might hold off on purchasing the rest of Minnesota's allotment. The antiviral medication has a shelf life of 7 years.
The Department of Health's Aggie Leitheiser said her agency is trying to balance its preparation goals with the possibility that the drugs might go to waste if the bird flu pandemic does not materialize.
"Unless we see a big change in the pandemic I don't know that we'll be going back for more. So I don't know that we'll say that we'll be at exactly 100 percent. But we're feeling moderately comfortable about the amount that we've gotten so far," Leitheiser said.
The Health Department has already spent more than $4 million on antiviral drugs. Leitheiser said her agency is exploring whether state money might be better spent on other pandemic supplies such as respirator masks.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
